Sinopharm Group Co. Ltd. (HKG:1099)
20.98
+0.18 (0.87%)
Feb 3, 2026, 4:08 PM HKT
Sinopharm Group Employees
Sinopharm Group had 108,217 employees as of December 31, 2024. The number of employees decreased by 7,742 or -6.68% compared to the previous year.
Employees
108,217
Change (1Y)
-7,742
Growth (1Y)
-6.68%
Revenue / Employee
5.79M HKD
Profits / Employee
71.48K HKD
Market Cap
64.91B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 108,217 | -7,742 | -6.68% |
| Dec 31, 2023 | 115,959 | 1,193 | 1.04% |
| Dec 31, 2022 | 114,766 | 1,532 | 1.35% |
| Dec 31, 2021 | 113,234 | 4,918 | 4.54% |
| Dec 31, 2020 | 108,316 | 14,552 | 15.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sipai Health Technology | 2,950 |
| ClouDr Group | 966 |
| ETHK Labs | 877 |
| Charmacy Pharmaceutical | 849 |
| Sinco Pharmaceuticals Holdings | 268 |
| Wanjia Group Holdings | 177 |
| Tai United Holdings | 171 |
| China Health Group | 127 |
Sinopharm Group News
- 8 months ago - Hong Kong stocks waver on China’s mixed economic data - South China Morning Post
- 10 months ago - Sinopharm Group: Mixed Read-Throughs From Peer Disclosures And Management Guidance - Seeking Alpha
- 1 year ago - Sinopharm Group: The Focus Is On Working Capital And Profitability - Seeking Alpha
- 1 year ago - How AI and Sinopharm’s disruptive technologies are contributing to longer human life - The Times of India
- 5 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 5 years ago - Week In Review: WHO Close To Approving Global Use For 2 China COVID-19 Vaccines - Seeking Alpha
- 5 years ago - Diversifying Into Top-Ranked Sinopharm - Seeking Alpha
- 5 years ago - Week In Review: Sinopharm Transfers $4.6 Billion In Assets Including Two COVID-19 Vaccines - Seeking Alpha